Mitochondrial-targeted actions of lycopene : evidence, mechanisms and future directions

Abstract

Lycopene (LYC; C40H56), a dietary carotenoid, has emerged as a promising modulator of mitochondrial physiology across multiple cell types and animal models. Here we critically synthesize experimental evidence that LYC attenuates mitochondrial oxidative stress, preserves oxidative phosphorylation complex function and ATP production, reduces mitochondrial permeability transition and cytochrome-c–dependent apoptosis, and regulates mitochondrial quality-control pathways including mitophagy and (less consistently) biogenesis. Mechanistic readouts indicate activation of antioxidant axes (Nrf2/HO-1), modulation of SIRT1/SIRT3 and PGC-1 signaling, and downstream effects on Bcl-2 family proteins and caspase activation; targeted delivery systems (mitochondria-directed nanodots) further enhance mitochondrial targeting and functional rescue in neurodegeneration models. However, the literature shows substantial heterogeneity in experimental designs (dose, route, timing), mostly relies on injury/toxin paradigms, and frequently reports molecular changes without causal perturbation (genetic or pharmacologic) to establish mechanism. Importantly, data on mitochondrial dynamics (fusion/fission) remain sparse and mechanistic links between mitophagy, biogenesis and improved bioenergetics are often associative rather than causal. The objective of this review is to evaluate available evidence on how LYC modulates mitochondrial function, redox biology, biogenesis, dynamics, and autophagy (mitophagy), as well as mitochondria-dependent apoptosis, in animal and human cells, identify critical gaps, and propose experimental priorities to move the field toward translational studies. This work is concluded with concrete recommendations for mechanistic and translational research to validate LYC as a mitochondria-targeting agent.